WO2020231942A1
|
|
Peptides and conjugates for treatment of arthritis
|
EP2989121A1
|
|
Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
|
WO2012162565A2
|
|
Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions
|
WO2012162564A1
|
|
Method for inducing an immune response and formulations thereof
|
WO2012082803A2
|
|
Method for inducing an immune response against avian, swine, spanish, h1n1, h5n9 influenza viruses and formulations thereof
|
WO2009114869A2
|
|
Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
|
US2008131396A1
|
|
Method for altering the CD4/CD8 ratio and the mononuclear cellular infiltrate into a tumor
|
US2006257420A1
|
|
Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
|
US2006088544A1
|
|
Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
|
AU2005269400A1
|
|
A method for managing cholesterol with a serum-free and mitogen free cytokine mixture
|
AU2005260053A1
|
|
A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture
|
CA2568295A1
|
|
A method for altering the cd4/cd8 ratio and the mononuclear cellular infiltrate into a tumor
|
US2006257357A1
|
|
Method for modulating HLA class II tumor cell surface expression with a cytokine mixture
|
US6896879B2
|
|
Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture
|
AU2003210594A1
|
|
Peptide constructs for treating disease
|
WO03061589A2
|
|
Methods for treating diseases or conditions with peptide constructs
|
US6951647B2
|
|
T cell binding ligand peptides and method of inducing a cellular immune response
|
WO0189286A2
|
|
T cell binding ligand peptides, peptide constructs containing same and use thereof for treatment of immunological disorders
|
AU4134901A
|
|
Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
|
US6995237B1
|
|
Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions
|